Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
14,021 total articles
Morgan Stanley upgraded Booking Holdings to overweight from equal-weight in a note on Tuesday, assigning a $5,500 price target, down from $6,150. Analyst Brian Nowak argued Booking’s ability to own the customer, gather traveler data and convert that into high-margin direct business should preserve its central role in travel even as agentic tools de…
UBS Global Research downgraded Gerresheimer AG (ETR:GXIG) from "neutral" to "sell" and reduced its 12-month price target to €12.90 from €29, citing elevated leverage, lower growth and weaker margin assumptions. The broker highlighted unclear covenant terms after a debt renegotiation and noted the company has started sale processes for Centor and Mo…
Hims & Hers Health saw its shares fall 7.4% to $14.40 in premarket trading after the company issued a first-quarter revenue forecast below analyst expectations. Management cited regulatory pressure tied to its weight-loss offerings and higher spending on international expansion. Several Wall Street firms reacted with downgrades, lower price targets…
U.S. stock futures inched higher Tuesday following a prior session selloff, with investors parsing uncertainty around global trade and concerns about AI-driven disruption. Corporate reports and company-specific developments pushed a number of names in premarket trading: Home Depot, Keurig Dr Pepper and AMD posted notable gains, while Novo Nordisk, …
German Chancellor Friedrich Merz makes his first trip to China as chancellor leading a delegation of top business executives amid mounting economic tensions. The visit, which includes meetings with President Xi Jinping and Premier Li Qiang and stops at industry sites, seeks to secure economic agreements while German firms confront intense competiti…
AES Corp has entered a 20-year agreement to provide electricity to Google’s forthcoming data center in Wilbarger County, Texas. The pact includes construction of generation resources co-located with the facility and shared grid infrastructure to support Google’s expansion. The announcement came as AES stock ticked higher in premarket trade and foll…
Agillic A/S has provided guidance for 2026 that calls for subscription annual recurring revenue (ARR) growth of 5% to 10%, an EBITDA margin between 12% and 18%, and the generation of positive free cash flow. The company reported 2025 subscription ARR of DKK 56.7 million, total revenue of DKK 58.4 million and EBITDA of DKK 8.4 million, up from DKK 1…
Saudi Arabia's equity market closed lower on Tuesday, with the Tadawul All Share slipping 0.71% to a new one-month low. Sector losses in Media & Publishing, Hotels & Tourism and Building & Construction weighed on the market, while individual winners and losers produced sizable percentage swings. Commodity and currency benchmarks showed mixed moveme…
Eli Lilly shares fell about 2.2% Tuesday after reports that Novo Nordisk will cut U.S. list prices for its GLP-1 drugs, including Ozempic and Wegovy, by up to 50% starting Jan. 1, 2027. Novo Nordisk shares also declined roughly 3%. The announced price changes are intended to lower costs for patients with high deductibles or coinsurance tied to list…
The UK government will subject leading video-on-demand platforms, including Netflix and Amazon Prime Video, to stronger regulation enforced by Ofcom under secondary legislation implementing the Media Act 2024. Services with more than 500,000 UK users will enter a new Tier 1 category and must comply with a VoD standards code modelled on the Broadcas…
China equities have faced downward pressure so far this year led by internet and auto stocks, driven by earnings revisions in e-commerce and cooling sentiment toward AI hyperscalers. At the same time, market breadth has improved: more than 60% of MSCI China constituents are outperforming the index, with industrials, commodities and pharma/biotech a…
Fulcrum Therapeutics Inc. (NASDAQ: FULC) saw its stock decline about 20% on Tuesday after the company released 12-week results from the 20 mg cohort of its Phase 1b PIONEER trial of pociredir in sickle cell disease. Data from 12 evaluable patients showed a mean absolute fetal hemoglobin gain of 12.2 percentage points and improvements in markers of …
Futures tied to Canada’s primary equity gauge inched lower on Tuesday as investors weighed a cluster of cross-cutting risks: worries about the impact of powerful artificial intelligence models, unresolved questions over new U.S. global tariffs, and upcoming Canadian bank earnings that may reflect slower loan growth. Moves in materials stocks and co…
Major technology and infrastructure companies have struck a series of multi-billion-dollar contracts to secure artificial intelligence compute, chips and data-center capacity. Agreements span leading chipmakers, cloud providers, data-center operators and AI startups, with some arrangements including equity options, licensing of intellectual propert…
A widely circulated hypothetical report outlining a grim 2028 unemployment outcome tied to rapid AI-driven layoffs has unsettled markets already heavily exposed to the technology. Investors have moved out of software equities and into defensive names and parts of the AI supply chain perceived as durable winners, prompting sharp sectoral divergence …
AES Corporation shares climbed 2% following the announcement of multi-decade energy supply and management agreements with Google for a new data center in Wilbarger County, Texas. The arrangement includes 20-year Power Purchase Agreements, AES ownership and operation of generation assets, and a long-term energy management contract to provide powered…
UBS downgraded Belgian transmission operator Elia from "buy" to "neutral" while lifting its 12-month price target to €144 from €117, arguing that the stock's recent advance has already captured expected improvements in allowed returns across Germany and Belgium. The broker raised earnings and EBITDA forecasts on a higher assumed return on equity bu…
Advanced Micro Devices saw its stock climb 14% on Tuesday morning after unveiling an expanded multi-year, multi-generation deal with Meta to deploy as much as 6 gigawatts of AMD Instinct GPUs for AI infrastructure. The agreement includes a staged shipment schedule beginning in the second half of 2026, a performance-linked warrant for up to 160 mill…
Palvella Therapeutics shares climbed 15% after the company reported positive topline results from its Phase 3 SELVA trial of QTORIN 3.9% rapamycin anhydrous gel for microcystic lymphatic malformations. The study met its primary endpoint and a pre-specified key secondary endpoint with strong statistical significance, showed favorable tolerability an…
The UK’s Information Commissioner’s Office (ICO) has fined Reddit £14.47 million after determining the platform failed to handle children’s personal information lawfully. The regulator found that age-verification measures were not in place until July 2025 and that Reddit subsequently relied on user self-declaration, which it deemed insufficient to …
Thermon saw a sharp premarket gain after Ceco Environmental announced plans to merge with the company in a $2.2 billion transaction. Ceco also updated its full-year guidance higher, citing a record sales pipeline, its largest-ever backlog and strong bookings momentum, while noting the expected financial benefits of the merger are not included in th…
HSBC analysts contend that traditional enterprise software will remain the primary conduit for artificial intelligence in large companies. The bank cautions that foundation models have limitations that make them unlikely to displace established enterprise platforms, and says 2026 will mark the start of meaningful monetization inside software.
Nykode Therapeutics ASA (OSE:NYKD) released an interim update from its VB-C-03 clinical trial on Tuesday in a short statement that provided no detailed results. The company, which develops cancer immunotherapies and vaccines, did not outline a schedule for further data releases or describe next steps for the program. The announcement was accompanie…
UBS cut its rating on Galenica AG to sell from neutral and trimmed its 12-month price target to CHF86 from CHF85, arguing the stock already prices in high-single-digit revenue growth and above-consensus margin expansion. The bank warns that planned relaxation of Swiss rules on online OTC drug shipments by FY29 could undercut pricing and growth, whi…
Telefonica's chief executive acknowledged that conditions in Venezuela have changed, but stressed that the company's approach to disposing of certain Latin American assets remains unchanged. The firm continues to review its footprint in the region and has not set a timetable for potential sales as it pursues portfolio optimization across multiple m…
